Adaptive Decision Support for Addiction Treatment (ADAPT) Factorial Trial
Status
Conditions
Treatments
Study type
Funder types
Identifiers
Details and patient eligibility
About
This study is stage 1 of a larger study which refines and optimizes the EMBED* clinical decision support (CDS; see NCT03658642) to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder.
This study does not have open enrollment. Investigators will use a Multiphase Optimization STrategy (MOST) framework study with preparation, optimization, and confirmatory phases. In the current project, optimization phase, stage1 investigators will conduct a 2x2x2 factorial trial in which they expand EMBED to include sustainable implementation strategies: nurse prompt for withdrawal assessment, and targeted clinician prompt to use the CDS along with patient resources to promote equity and motivate readiness to start treatment.
Later study phases will include optimization phase, stage 2: rapid-cycle randomized testing, and evaluation phase: a randomized trial of the optimized package compared to the original EMBED and the evaluation phase in which investigators will compare the efficacy of the optimized, multicomponent CDS package to the original EMBED CDS on ED-initiation of buprenorphine rates in patients with OUD in a randomized trial.
*EMBED is a user centered, clinician facing clinical decision support system integrated into the electronic health record workflow to facilitate initiating buprenorphine in the emergency department by: diagnosing opioid use disorder with a checklist based on the diagnostic criteria of the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, fifth edition), assessing the severity of withdrawal with the Clinical Opioid Withdrawal Scale (COWS), motivating patients to accept treatment with a scripted brief negotiation interview, and automating the electronic health record workflow, including clinical and after visit documentation, order entry, prescribing, and referral for ongoing treatment in the community
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Emergency department patient
- 18 years of age or older
- Moderate to severe opioid use disorder
Exclusion criteria
- Under 18 years of age
- Pregnant
- Currently receiving medication for opioid use disorder
Trial design
Primary purpose
Allocation
Interventional model
Masking
1,129 participants in 8 patient groups
Trial contacts and locations
Loading...
Central trial contact
Laurel Buchanan, MA; Edward Melnick, MD, MHS
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal